Acrivon Therapeutics, Inc. Common Stock (ACRV) SEC Filings

Acrivon Therapeutics, Inc. Common Stock (ACRV) SEC EDGAR filings (8-K, 10-Q, DEF 14A, 10-K), newest first; latest 8-K filed 2026-08-12. Every filing links to the canonical SEC document. First-party data.

SEC filings — source: EDGAR

Filed	Form	Title
2026-08-12	8-K	8-K filed 2026-08-12 by Acrivon Therapeutics, Inc.
2026-08-12	10-Q	10-Q filed 2026-08-12 by Acrivon Therapeutics, Inc.
2026-06-17	8-K	8-K filed 2026-06-17 by Acrivon Therapeutics, Inc.
2026-05-13	10-Q	10-Q filed 2026-05-13 by Acrivon Therapeutics, Inc.
2026-05-13	8-K	8-K filed 2026-05-13 by Acrivon Therapeutics, Inc.
2026-04-30	DEF 14A	DEF 14A filed 2026-04-30 by Acrivon Therapeutics, Inc.
2026-03-19	8-K	8-K filed 2026-03-19 by Acrivon Therapeutics, Inc.
2026-03-19	10-K	10-K filed 2026-03-19 by Acrivon Therapeutics, Inc.
2026-03-02	8-K	8-K filed 2026-03-02 by Acrivon Therapeutics, Inc.
2026-02-27	8-K	8-K filed 2026-02-27 by Acrivon Therapeutics, Inc.
2026-01-08	8-K	8-K filed 2026-01-08 by Acrivon Therapeutics, Inc.
2026-01-08	8-K	8-K filed 2026-01-08 by Acrivon Therapeutics, Inc.
2025-11-13	10-Q	10-Q filed 2025-11-13 by Acrivon Therapeutics, Inc.
2025-11-13	8-K	8-K filed 2025-11-13 by Acrivon Therapeutics, Inc.
2025-09-05	8-K	8-K filed 2025-09-05 by Acrivon Therapeutics, Inc.
2025-08-13	8-K	8-K filed 2025-08-13 by Acrivon Therapeutics, Inc.
2025-08-13	10-Q	10-Q filed 2025-08-13 by Acrivon Therapeutics, Inc.
2025-06-13	8-K	8-K filed 2025-06-13 by Acrivon Therapeutics, Inc.
2025-05-14	10-Q	10-Q filed 2025-05-14 by Acrivon Therapeutics, Inc.
2025-05-14	8-K	8-K filed 2025-05-14 by Acrivon Therapeutics, Inc.
2025-04-25	DEF 14A	DEF 14A filed 2025-04-25 by Acrivon Therapeutics, Inc.
2025-04-07	8-K	8-K filed 2025-04-07 by Acrivon Therapeutics, Inc.
2025-03-27	10-K	10-K filed 2025-03-27 by Acrivon Therapeutics, Inc.
2025-03-27	8-K	8-K filed 2025-03-27 by Acrivon Therapeutics, Inc.
2025-03-25	8-K	8-K filed 2025-03-25 by Acrivon Therapeutics, Inc.
2025-03-14	8-K	8-K filed 2025-03-14 by Acrivon Therapeutics, Inc.
2024-11-13	10-Q	10-Q filed 2024-11-13 by Acrivon Therapeutics, Inc.
2024-11-13	8-K	8-K filed 2024-11-13 by Acrivon Therapeutics, Inc.
2024-10-11	8-K	8-K filed 2024-10-11 by Acrivon Therapeutics, Inc.
2024-09-16	8-K	8-K filed 2024-09-16 by Acrivon Therapeutics, Inc.

ACRV overview · ACRV earnings · ACRV financials · ACRV KPIs · ACRV investor relations · ACRV ownership · ACRV peers

Data sourced from U.S. SEC EDGAR. Not personalized investment advice.